Evolent Health, Inc. (EVH)
NYSE: EVH · Real-Time Price · USD
4.620
-0.210 (-4.35%)
Nov 17, 2026, 4:00 PM EST - Market closed

Evolent Health Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-507.69-534.51-61.62-113.04-19.16-37.6
Depreciation & Amortization
86.5592.6571.1796.7240.233.54
Other Amortization
39.2137.833.9541.4652.3657.59
Loss (Gain) From Sale of Assets
-14.87-14.87-8.11--45.94
Asset Writedown & Restructuring Costs
39839824.1924.07--
Loss (Gain) on Equity Investments
-0.03-0.373.44-1.29-4.57-13.18
Stock-Based Compensation
43.0539.7439.7540.533.9816.71
Other Operating Activities
12.3977.7824.4624.18-7.8834.49
Change in Accounts Receivable
-66.5773.732.06-164.69-102.98-5.78
Change in Accounts Payable
-30.416.644.25-6.7213.177.25
Change in Unearned Revenue
-1.05-1.3-3.47-0.26-6.51-0.74
Change in Other Net Operating Assets
106.3-136.42-149.4193.57-10.62-14.38
Operating Cash Flow
64.8838.8418.77142.58-11.5538.75
Operating Cash Flow Growth
-107.00%-86.84%---

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-29.62-91.53-33.12-28.75-47.53-27.5
Sale of Property, Plant & Equipment
91.3191.31-0.58-3.49
Cash Acquisitions
---19.5-388.25-248.11-46.5
Investment in Securities
0.3-0.01-10.310.875.5511.72
Other Investing Activities
----30.9743
Investing Cash Flow
61.99-0.23-62.93-415.54-259.12-15.79

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-408.0558.58647.49219.74-
Long-Term Debt Repaid
--342.98--464.2--98.85
Net Debt Issued (Repaid)
-105.4265.0658.58183.29219.74-98.85
Issuance of Common Stock
--3.4612.524.4513.29
Repurchase of Common Stock
-3.19-45.22-15.7-15.29-18.32-3.85
Preferred Dividends Paid
--11.13-20.09-18.79--
Dividends Paid
--11.13-20.09-18.79--
Other Financing Activities
-3.94-44.64-26.82-48.39-74.3359.86
Financing Cash Flow
-112.55-35.92-0.57281.34131.54-29.55

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-1.47-0.49-0.23-0.08-0.66-0.05
Net Cash Flow
12.852.2-44.968.3-139.78-6.64

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
35.26-52.69-14.35113.84-59.0811.25
Free Cash Flow Growth
------
Free Cash Flow Margin
1.50%-2.81%-0.56%5.80%-4.37%1.24%
Free Cash Flow Per Share
0.31-0.46-0.131.02-0.630.13
Levered Free Cash Flow
142.8540.96-48162.112.5793.58
Unlevered Free Cash Flow
174.4569.08-36.09192.172091.42

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
41.1641.1620.2153.596.277.11
Cash Income Tax Paid
2.62.61.44.91.40.55
Change in Working Capital
8.28-57.38-116.5621.89-106.94-13.65
SEC Filings: 10-K · 10-Q